 | | PRD_000824 | | Name: | SLKIDNED peptide | | Formula: | C38 H63 N10 O16 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000825 | | Name: | ATKIDNLD peptide | | Formula: | C37 H63 N10 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000826 | | Name: | SRKIDNLD peptide | | Formula: | C39 H69 N13 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000827 | | Name: | SHKIDNLD peptide | | Formula: | C39 H64 N12 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000829 | | Name: | OS1 peptide | | Formula: | C51 H87 N17 O16 S3 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000833 | | Name: | 5-methyltetrahydrofolate pentaglutamate | | Formula: | C40 H53 N11 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000854 | | Name: | DB6 peptide | | Formula: | C57 H77 N13 O11 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000855 | | Name: | DB5 peptide | | Formula: | C49 H74 N15 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000870 | | Name: | bisubstrate inhibitor | | Formula: | C23 H30 N6 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000882 | | Name: | MonodeChloro- Teicoplanin A2-2 | | Formula: | C88 H98 Cl N9 O33 | | Definition date: | 2013-03-06 | | Last modified: | 2013-06-03 |
|
 | | PRD_000892 | | Name: | METHYL (2R)-1-[(6S,9S,12S,13S,17S,20S,23R)-9-(3-AMINO-3-OXOPROPYL)-12,23-DIBENZYL-13-HYDROXY-2,2,8,20,22-PENTAMETHYL-17-(2-METHYLPROPYL)-4,7,10,15,18,21,24-HEPTAOXO-6-(PROPAN-2-YL)-3-OXA-5,8,11,16,19,22-HEXAAZATETRACOSAN-24-YL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C52 H78 N8 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_002042 | | Name: | (5R,6R,8S)-8-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-5-CYCLOHEXYL-6-HYDROXY-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE | | Formula: | C20 H27 N6 O3 | | Description: | P2- substituted N-acyl-prolylpyrrolidine inhibitor | | Definition date: | 2013-05-29 | | Last modified: | 2013-05-29 |
|
 | | PRD_002048 | | Name: | PERINDOPRILAT | | Formula: | C17 H28 N2 O5 | | Definition date: | 2013-05-29 | | Last modified: | 2013-05-29 |
|
 | | PRD_002050 | | Name: | (S)-1-N2-(1-CARBOXY-3-PHENYLPROPYL)-L-LYSYL-L-TRYPTOPHAN | | Formula: | C27 H34 N4 O5 | | Description: | AnCE-Lisinopril-Tryptophan analogue | | Definition date: | 2013-05-29 | | Last modified: | 2013-05-29 |
|
 | | PRD_002070 | | Name: | tert-butyl N-[[1-[(3S,5S)-5-[(2S)-2-[azanyl(oxidanyl)methyl]pyrrolidin-1-yl]carbonyl-1-(4-phenylbutanoyl)pyrrolidin-3-yl]-1,2,3-triazol-4-yl]methyl]carbamate | | Formula: | C28 H41 N7 O5 | | Description: | P2- substituted N-acyl-prolylpyrrolidine inhibitor | | Definition date: | 2013-05-29 | | Last modified: | 2013-05-29 |
|
 | | PRD_002071 | | Name: | 1-[(2S,4S)-4-[4-(4-fluorophenyl)-1,2,3-triazol-1-yl]-2-pyrrolidin-1-ylcarbonyl-pyrrolidin-1-yl]-4-phenyl-butan-1-one | | Formula: | C27 H30 F N5 O2 | | Description: | P2-substituted N-acyl-prolylpyrrolidine inhibitor | | Definition date: | 2013-05-29 | | Last modified: | 2013-05-29 |
|
 | | PRD_002076 | | Name: | RAMIPRILAT | | Formula: | C21 H28 N2 O5 | | Definition date: | 2013-05-29 | | Last modified: | 2013-05-29 |
|
 | | PRD_000915 | | Name: | benzyl [(2S)-1-({(2R)-1-[(1S,2S)-2-{[(2R,3S,4S)-3-formyl-2-hydroxy-4-methylhexanoyl]amino}cyclopropyl]-4-phenylbutan-2-yl}amino)-1-oxopropan-2-yl]carbamate | | Formula: | C32 H43 N3 O6 | | Definition date: | 2013-04-17 | | Last modified: | 2013-04-17 |
|
 | | PRD_001012 | | Name: | Pyrrhocoricin | | Formula: | C72 H120 N16 O18 | | Definition date: | 2013-04-17 | | Last modified: | 2013-04-17 |
|
 | | PRD_000903 | | Name: | (2R)-2,4-dihydroxy-3,3-dimethyl-N-{3-oxo-3-[(pyridin-3-ylmethyl)amino]propyl}butanamide | | Formula: | C15 H23 N3 O4 | | Definition date: | 2013-04-10 | | Last modified: | 2013-04-10 |
|
 | | PRD_000907 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-4-methyl-1-oxopentan-2-yl]-L-leucinamide | | Formula: | C26 H41 N3 O5 | | Definition date: | 2013-04-10 | | Last modified: | 2013-04-10 |
|
 | | PRD_001043 | | Name: | (2R)-2,4-dihydroxy-3,3-dimethyl-N-[3-oxo-3-(pentylamino)propyl]butanamide | | Formula: | C14 H28 N2 O4 | | Definition date: | 2013-04-10 | | Last modified: | 2013-04-10 |
|
 | | PRD_000889 | | Name: | (2R,4R)-4-methyl-1-(N~2~-{[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonyl}-L-arginyl)piperidine-2-carboxylic
acid | | Formula: | C23 H36 N6 O5 S | | Definition date: | 2013-03-13 | | Last modified: | 2013-03-13 |
|
 | | PRD_000830 | | Name: | N-[(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-alpha-glutamyl-L-alpha-glutamine | | Formula: | C35 H35 Br Cl N4 O10 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000865 | | Name: | N-[(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-a
lanyl-L-alaninamide | | Formula: | C31 H31 Br Cl N4 O6 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
